We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – Products

T cells attacking a cancer cell.
Product News

Efficient Transduction of CAR Into T Cells

AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.
Diving Deep Into Cell Therapy: An Industry Perspective content piece image
Whitepaper

Diving Deep Into Cell Therapy: An Industry Perspective

Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.
CAR T: A Promising Cell Therapy for Cancer Treatment content piece image
App Note / Case Study

CAR T: A Promising Cell Therapy for Cancer Treatment

CAR-T cell therapy has emerged as one of the most promising novel treatments in the fight against cancer.
The Certis logo
Product News

Certis Oncology Solutions Announces Three Abstracts Accepted for Presentation at AACR Annual Meeting

Certis Oncology Solutions has announced that three abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting.
The Cantargia logo.
Product News

Cantargia To host R&D Day on New Clinical Results of Nadunolimab in Pancreatic Cancer

Cantargia has announced it will host an R&D Day focusing on new clinical results and biomarker data for its lead asset, the IL1RAP-binding antibody nadunolimab, in pancreatic cancer patients.
The CureSearch logo
Product News

CureSearch To Fund Phase I Clinical Trial for Pediatric Brain Cancer

CureSearch for Children’s Cancer has announced that it will fund a Phase I clinical trial to bring new therapies to pediatric brain cancer patients, including those with limited or no treatment options.
The EpicentRx logo.
Product News

EpicentRx Receives Fast Track Designation From the U.S. FDA for Lead Asset

EpicentRx, Inc. has announced that the FDA has granted Fast Track Designation to RRx-001 for the prevention/attenuation of severe oral mucositis in chemotherapy and radiation-treated head & neck cancer patients.
The Thermo Fisher Scientific logo.
Product News

Thermo Fisher and ArsenalBio Advancing Clinical Manufacturing for Cancer Treatments

Thermo Fisher Scientific and Arsenal Biosciences, Inc. have announced an update to their strategic collaboration to further the development of manufacturing processes for new cancer treatments.
The Cardiff Oncology logo.
Product News

Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase II Randomized Trial

Cardiff Oncology, Inc. has announced that the first patient was dosed last month with its investigational drug onvansertib in its Phase II ONSEMBLE trial.
Metabolic Preconditioning For Improved CAR-T Cell Therapy content piece image
App Note / Case Study

Metabolic Preconditioning for Improved CAR-T Cell Therapy

Metabolism is a key driver of CAR-T cell fitness and function. Hence, metabolic preconditioning methods can enhance the bioenergetic capacity of CAR-T cells in culture, supporting their persistence and antitumor activity
Advertisement